Therapeutic targeting of transcriptional cyclin-dependent kinases

The fact that many cancer types display transcriptional addiction driven by dysregulation of oncogenic enhancers and transcription factors has led to increased interest in a group of protein kinases, known as transcriptional cyclin dependent kinases (tCDKs), as potential therapeutic targets. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Galbraith, Matthew D., Bender, Heather, Espinosa, Joaquín M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602565/
https://www.ncbi.nlm.nih.gov/pubmed/30409083
http://dx.doi.org/10.1080/21541264.2018.1539615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602565/
https://www.ncbi.nlm.nih.gov/pubmed/30409083
http://dx.doi.org/10.1080/21541264.2018.1539615

Ejemplares similares